Jefferies Group LLC Clovis Oncology, Inc. Call Options Transaction History

Jefferies Group LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 May 14, 2021	SELL	$4.81 - $10.34 $53,871 - $115,808	-11,200 Closed	0 $0
Q4 2020 Sep 21, 2023	BUY	$4.13 - $6.41 $46,256 - $71,792	11,200 New	11,200 $53,000
Q1 2020 May 15, 2020	SELL	$3.77 - $11.0 $586,235 - $1.71 Million	-155,500 Reduced 93.28%	11,200 $71,000
Q4 2019 Feb 13, 2020	BUY	$3.0 - $16.43 $314,400 - $1.72 Million	104,800 Added 169.31%	166,700 $1.74 Million
Q3 2019 Nov 13, 2019	BUY	$3.93 - $15.35 $230,691 - $901,045	58,700 Added 1834.38%	61,900 $243,000
Q2 2019 Aug 14, 2019	SELL	$12.81 - $25.67 $935,130 - $1.87 Million	-73,000 Reduced 95.8%	3,200 $48,000
Q1 2019 May 15, 2019	SELL	$17.66 - $30.28 $708,166 - $1.21 Million	-40,100 Reduced 34.48%	76,200 $1.89 Million
Q4 2018 Feb 14, 2019	BUY	$11.63 - $32.67 $779,210 - $2.19 Million	67,000 Added 135.9%	116,300 $2.09 Million
Q3 2018 Nov 14, 2018	BUY	$29.37 - $49.48 $1.45 Million - $2.44 Million	49,300 New	49,300 $1.45 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.